These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The significance of irregularly contracted cells and hemighosts in sickle cell disease. Siow W; Matthey F; Bain BJ Am J Hematol; 2017 Sep; 92(9):966-967. PubMed ID: 28120521 [No Abstract] [Full Text] [Related]
5. Organizational differences in the membrane proteins of normal and irreversibly sickled erythrocytes. Rubin RW; Milikowski C; Wise GE Biochim Biophys Acta; 1980; 595(1):1-8. PubMed ID: 7349873 [TBL] [Abstract][Full Text] [Related]
6. Membrane protein organization in ATP-depleted and irreversibly sickled red cells. Palek J; Liu SC J Supramol Struct; 1979; 10(1):79-96. PubMed ID: 108478 [No Abstract] [Full Text] [Related]
7. Failure to demonstrate red cell membrane protein abnormalities in sickle cell anaemia. Ballas SK; Burka ER Br J Haematol; 1980 Dec; 46(4):627-9. PubMed ID: 7437340 [No Abstract] [Full Text] [Related]
8. Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia. Honig GR; Gunay U; Mason RG; Vida LN; Ferenc C Pediatr Res; 1976 Jun; 10(6):613-20. PubMed ID: 1272638 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia. Ponnazhagan S; Sarkar R Indian J Pediatr; 1992; 59(1):85-90. PubMed ID: 1377179 [TBL] [Abstract][Full Text] [Related]
10. The clinical pathophysiology of sickle cell disease. Embury SH Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018 [TBL] [Abstract][Full Text] [Related]
11. Abnormal membrane phospholipid asymmetry in sickle erythrocytes and its pathophysiologic significance. Lubin B; Chiu D; Roelofsen B; Van Deenen LL Prog Clin Biol Res; 1981; 56():171-93. PubMed ID: 7330009 [No Abstract] [Full Text] [Related]
12. Erythrocyte and plasma magnesium in sickle-cell anaemia. Olukoga AO; Adewoye HO; Erasmus RT; Adedoyin MA East Afr Med J; 1990 May; 67(5):348-54. PubMed ID: 2390957 [TBL] [Abstract][Full Text] [Related]
13. Further data on one of the first examples of sickle cell alpha-thalassemia disease. Bermek E; Aksoy M; Almis G; Kutlar A Hemoglobin; 1979; 3(6):471-4. PubMed ID: 511587 [No Abstract] [Full Text] [Related]
15. Hemoglobin synthesis studies of a family with alpha-thalassemia trait and sickle cell trait. Shaeffer JR; DeSimone J; Kleve LJ Biochem Genet; 1975 Dec; 13(11-12):783-8. PubMed ID: 1200978 [TBL] [Abstract][Full Text] [Related]
16. [Biological profile of sickle cell anemia in Morocco. A propos of 85 cases]. Omari M; Naji M; Agoumi N Maghrib Tibbi; 1982; 4(2-3):175-82. PubMed ID: 7182694 [No Abstract] [Full Text] [Related]
17. Reduced erythrocyte membrane protein methylation in sickle cell anemia. Ro JY; Neilan B; Magee PN; Paik WK; Kim S J Biol Chem; 1981 Oct; 256(20):10572-6. PubMed ID: 7287725 [TBL] [Abstract][Full Text] [Related]
18. Red cell distribution width in sickle cell disease. Webster P; Castro O Ann Clin Lab Sci; 1986; 16(4):274-7. PubMed ID: 3740796 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic variation in sickle cell trait. Esan GJ; Adesina TA Scand J Haematol; 1974; 13(5):370-6. PubMed ID: 4453812 [No Abstract] [Full Text] [Related]
20. Role of membrane-bound haemoglobin products in oxidative damage in sickle cell membranes. Rice-Evans C; Baysal E Acta Haematol; 1987; 78(2-3):105-8. PubMed ID: 3120454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]